Generic medications in ophthalmology
- PMID: 23143788
 - DOI: 10.1136/bjophthalmol-2012-302245
 
Generic medications in ophthalmology
Abstract
The purpose of this review is to discuss the process of genericisation of medications in the US and Europe with a focus on ophthalmic drugs. Regulatory guidelines of the US Food and Drug Administration and the European Medicines Agency will be discussed, and the advantages and concerns of genericisation will be explored. We will look at various studies concerning the safety and efficacy of generic drugs compared to their branded counterparts. In particular, the challenges of assuring bioequivalence and therapeutic equivalence in topical ophthalmic drugs will be examined.
Comment in
- 
  
  Authors' response: generic medications in ophthalmology.Br J Ophthalmol. 2013 Jun;97(6):795. doi: 10.1136/bjophthalmol-2013-303159. Epub 2013 Mar 7. Br J Ophthalmol. 2013. PMID: 23471822 No abstract available.
 - 
  
  Authors' response.Br J Ophthalmol. 2013 Jun;97(6):795-6. doi: 10.1136/bjophthalmol-2013-303307. Epub 2013 Mar 15. Br J Ophthalmol. 2013. PMID: 23505302 No abstract available.
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical